source
- Pharma marketers urged to adopt share-of-answer strategy as AI use surges among physiciansPharma marketers are planning for 2027 as artificial intelligence reshapes how clinicians seek clinical answers. The rise of AI tools means that traditional metrics like share of voice and broad om…
- Roche bets up to $2.3B on Hanmi’s early-stage muscle-building obesity assetRoche is spending $190 million upfront to license a non-incretin obesity drug from South Korea’s Hanmi Pharm. The deal represents the latest in a string of obesity pacts inked by Roche in recent ye…Endpoints · 25m ago↗ source
- Option-to-acquire deals remain rare in biotech's buzzy M&A season